Last updated: August 06, 2026

Application No. 18/004,158

MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF

Non-Final OA

Filed

Jan 03, 2023

Priority

Jul 06, 2020 — provisional 63/048,488 +4 more

Examiner

QIAN, CELINE X

Art Unit

1637

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Immunocell Therapeutics Inc.

OA Round

1 (Non-Final)

This examiner grants 48% of cases after interview

— +16.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 779 resolved cases, 2023–2026

Examiner Intelligence

QIAN, CELINE X View full profile →

Grants 48% of resolved cases

Career Allowance Rate

371 granted / 779 resolved

-12.4% vs TC avg

Strong +17% interview lift

Without

With

+16.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

48 currently pending

Career history

833

Total Applications

across all art units

Statute-Specific Performance

§101

8.0%

-32.0% vs TC avg

§103

29.7%

-10.3% vs TC avg

§102

18.0%

-22.0% vs TC avg

§112

36.2%

-3.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 779 resolved cases

Prosecution Timeline

Jan 03, 2023

Application Filed

Mar 11, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/713,025

Patent 12685775

OLIGONUCLEOTIDES WITH NUCLEOSIDE ANALOGS

4y 3m to grant Granted Jul 21, 2026

19/042,264

Patent 12649699

PHOSPHATE SENSING MICROBIAL GENE SWITCH

1y 4m to grant Granted Jun 09, 2026

18/471,187

Patent 12642874

METHODS OF TREATING EYE DISEASES

2y 8m to grant Granted Jun 02, 2026

17/810,373

Patent 12624363

PLASMID ADDICTION SYSTEM TO DRIVE DESIRED GENE EXPRESSION

3y 10m to grant Granted May 12, 2026

18/326,689

Patent 12624353

METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES

2y 11m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

48%

Grant Probability

64%

With Interview (+16.6%)

3y 8m (~1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 779 resolved cases by this examiner. Grant probability derived from career allowance rate.